A different CHE-DE study demonstrated similar DE-mediated attenuation of bradykinin-induced tPA release in participants with coronary artery disease and a history of previous myocardial infarction under comparable exposure conditions and sampling timepoints [194]. This evidence concerns the gene PLAT and coronary artery disorder.